Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19

The prevalence of venous thromboembolism (VTE) is high in critically ill patients with COVID-19. Dosing of Low Molecular Weight Heparin (LMWH) for thromboprophylaxis in patients with severe COVID-19 is subject to ongoing debate. In this brief report, we describe our study where we retrospectively ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, David Oliver, Main-Ian, Alexander, Tebbutt, Jessie, Thrasher, Maya, Waite, Alicia, Welters, Ingeborg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591599/
https://www.ncbi.nlm.nih.gov/pubmed/34781984
http://dx.doi.org/10.1186/s12959-021-00337-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591599/
https://www.ncbi.nlm.nih.gov/pubmed/34781984
http://dx.doi.org/10.1186/s12959-021-00337-z

Ejemplares similares